Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Fifth INTEnsive pReventing Secondary Injury in Acute Cerebral Haemorrhage Trial Within ACT-GLOBAL

NCT06763055 is registered in ClinicalTrials.gov with The George Institute as lead sponsor.

NCT NCT06763055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06763055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Fifth INTEnsive pReventing Secondary Injury in Acute Cerebral Haemorrhage Trial Within ACT-GLOBAL
Lead sponsor
The George Institute
Phase
Phase 3
Overall status
Recruiting
Start date
February 27, 2025
Completion date
January 31, 2028
Enrollment
2,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute intracerebral haemorrhage, acute stroke, intracerebral hemorrhage, spontaneous intracerebral hemorrhage, supratentorial intracerebral haemorrhage